Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Medical Officer

SrVP/CFO/Prin Fin & Acct Ofcr

President, CEO

SrVP/CFO/Prin. Fin&Acctg. Off

SVP, Chief Financial Officer

SVP, Chief Operating Officer

SVP, Chief Medical Officer

Chairman & CEO

SVP, Chief Business Officer

SVP, Chief Scientific Officer

Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing synthetic lethality-based cancer therapeutics that targets DNA damage response pathways. Its lead product candidate is the ATRN-119 that is in Phase I clinical trials for treating advanced solid tumors, ovarian, breast, and prostate cancers. The company is also developing ATRN-1051, ATRN-354, and APRE-DDRi for the treatment of advanced solid tumors. The company is headquartered in Doylestown, Pennsylvania.

Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing synthetic lethality-based ...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-05-01	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2024-03-28	Premium	acquired	Premium	Premium	Premium	SrVP/CFO/Prin Fin & Acct Ofcr
2024-03-28	Premium	acquired	Premium	Premium	Premium	President, CEO
2024-03-13	Premium	bought	Premium	Premium	Premium	-
2024-03-13	Premium	bought	Premium	Premium	Premium	-
2024-03-13	Premium	bought	Premium	Premium	Premium	President, CEO
2024-03-13	Premium	bought	Premium	Premium	Premium	SrVP/CFO/Prin Fin & Acct Ofcr
2023-08-23	Premium	acquired	Premium	Premium	Premium	-
2023-08-23	Premium	acquired	Premium	Premium	Premium	-
2023-08-23	Premium	acquired	Premium	Premium	Premium	-
2023-08-23	Premium	acquired	Premium	Premium	Premium	-
2023-08-23	Premium	acquired	Premium	Premium	Premium	-
2023-08-23	Premium	acquired	Premium	Premium	Premium	-
2023-06-07	Premium	bought	Premium	Premium	Premium	-
2023-06-06	Premium	bought	Premium	Premium	Premium	-
2023-03-09	Premium	acquired	Premium	Premium	Premium	President, CEO
2023-02-27	Premium	acquired	Premium	Premium	Premium	SrVP/CFO/Prin Fin & Acct Ofcr
2023-01-30	Premium	acquired	Premium	Premium	Premium	SrVP/CFO/Prin. Fin&Acctg. Off
2022-08-23	Premium	acquired	Premium	Premium	Premium	-
2022-08-23	Premium	acquired	Premium	Premium	Premium	-
2022-08-23	Premium	acquired	Premium	Premium	Premium	President, CEO
2022-08-23	Premium	acquired	Premium	Premium	Premium	-
2022-08-23	Premium	acquired	Premium	Premium	Premium	-
2022-07-28	Premium	acquired	Premium	Premium	Premium	-
2022-07-28	Premium	acquired	Premium	Premium	Premium	-

APRE - Aprea Therapeutics Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for APRE